Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays

R Grifantini, E Bartolini, A Muzzi, M Draghi… - Nature …, 2002 - nature.com
R Grifantini, E Bartolini, A Muzzi, M Draghi, E Frigimelica, J Berger, G Ratti, R Petracca…
Nature biotechnology, 2002nature.com
We have used DNA microarrays to follow Neisseria meningitidis serogroup B (MenB) gene
regulation during interaction with human epithelial cells. Host-cell contact induced changes
in the expression of 347 genes, more than 30% of which encode proteins with unknown
function. The upregulated genes included transporters of iron, chloride, amino acids, and
sulfate, many virulence factors, and the entire pathway of sulfur-containing amino acids.
Approximately 40% of the 189 upregulated genes coded for peripherally located proteins …
Abstract
We have used DNA microarrays to follow Neisseria meningitidis serogroup B (MenB) gene regulation during interaction with human epithelial cells. Host-cell contact induced changes in the expression of 347 genes, more than 30% of which encode proteins with unknown function. The upregulated genes included transporters of iron, chloride, amino acids, and sulfate, many virulence factors, and the entire pathway of sulfur-containing amino acids. Approximately 40% of the 189 upregulated genes coded for peripherally located proteins, suggesting that cell contact promoted a substantial reorganization of the cell membrane. This was confirmed by fluorescence activated cell sorting (FACS) analysis on adhering bacteria using mouse sera against twelve adhesion-induced proteins. Of the 12 adhesion-induced surface antigens, 5 were able to induce bactericidal antibodies in mice, demonstrating that microarray technology is a valid approach for identifying new vaccine candidates and nicely complements other genome mining strategies used for vaccine discovery.
nature.com